NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,590.00
+85.00 (3.39%)
Sep 1, 2026, 3:30 PM KST

NeoImmuneTech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-24,448-31,796-40,883-53,405-60,406-52,482
Depreciation & Amortization
2,8252,4983,6733,2102,8021,873
Loss (Gain) From Sale of Assets
-37.48-213.95321.851.8912.78108.48
Asset Writedown & Restructuring Costs
2.0340.1488.92---
Stock-Based Compensation
-63.43-426.711,4125,8935,6319,204
Provision & Write-off of Bad Debts
157.15118.84936.2225.98--
Other Operating Activities
1,6065,923-2,018-2,1382,909-271.91
Change in Accounts Receivable
-1,329-12.38-18.9---
Change in Other Net Operating Assets
-1,658-1,183-2,975-3,5486,6467,682
Operating Cash Flow
-23,639-25,053-39,062-49,761-42,405-33,887
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-82.15-79.64-1,549-791.39-2,477-2,710
Sale of Property, Plant & Equipment
101.01230.491.26-6.98-
Sale (Purchase) of Intangibles
-14,125-7,111----
Investment in Securities
554.67-9,445-12,403---
Other Investing Activities
1,0961,2782,3812,715836.55-1,119
Investing Cash Flow
-12,463-15,002-11,5712,087-3,150-3,828

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--12,403---
Long-Term Debt Repaid
--792.78-1,186-1,178-1,036-713.73
Net Debt Issued (Repaid)
-807.9-792.7811,217-1,178-1,036-713.73
Issuance of Common Stock
50,23148,688-41.26402.56115,763
Other Financing Activities
-1,034-1,036-0--0
Financing Cash Flow
48,37246,86011,217-1,136-633.32115,049

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2,429-1,373-1,592-97.54-3,075-682.37
Miscellaneous Cash Flow Adjustments
-0--0-0-0-
Net Cash Flow
9,8415,431-41,008-48,908-49,26376,652

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-23,721-25,133-40,612-50,552-44,881-36,596
Free Cash Flow Growth
------
Free Cash Flow Margin
-1347.80%-26504.37%-23835.33%---
Free Cash Flow Per Share
-190.38-213.57-411.85-511.40-454.42-384.18
Levered Free Cash Flow
-18,679-20,882-24,302-38,500-28,855-25,579
Unlevered Free Cash Flow
-17,114-19,366-23,849-38,360-28,692-25,442

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
198.17213.82221.25220.99253.77226.7
Cash Income Tax Paid
--20.6104.86133.6258.232.91
Change in Working Capital
-3,680-1,196-2,994-3,5486,6467,682